8-K

Company

Skye Bioscience, Inc.

Filed

October 3, 2023

Period of Report

September 29, 2023

Accession Number

0001516551-23-000079

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →